Preclinical and clinical evidence implicates a role for endogenous apolipoprotein E in modifying the response of the brain to focal and global ischemia. To investigate whether apoE modulates the neuronal response to glutamate excitotoxicity, we exposed primary neuronal glial cultures and a neuronal cell line to biologically relevant concentrations of apolipoprotein E prior to NMDA exposure. In both of these paradigms, apolipoprotein E exerted partial protective effects. At neuroprotective concentrations, however, apolipoprotein E failed to block NMDA-induced calcium influx to the same magnitude as the NMDA receptor antagonist MK-801. These results suggest that one mechanism by which apolipoprotein E modifies the central nervous system response to ischemia may be by reducing glutamate-induced excitotoxicity. © 2002 Elsevier Science (USA)
INTRODUCTION
Apolipoprotein E (apoE) is a 299-amino-acid protein with multiple biological properties. There are three common human isoforms of apoE, designated apoE2, E3, and E4, which differ by single amino acid substitutions at residues 112 and 158 (Weisgraber, 1994) . A growing body of evidence suggests a role for endogenous apoE in modifying the central nervous system (CNS) response to acute injury (Laskowitz et al., 1998) . In preclinical models of focal and global ischemia, the absence of endogenous apoE has been associated with a worsening of both histological and functional outcomes (Laskowitz et al., 1997; Sheng et al., 1999; Horsburgh et al., 2000) . These effects appear to be isoformspecific, with the presence of the APOE4 allele associated with worse outcome than that of the APOE3 allele (Sheng et al., 1998) . These observations are consistent with clinical data implicating the presence of the APOE4 allele with increased neurological morbidity following stroke, intracranial hemorrhage, and cardiac arrest (Alberts et al., 1995; Laskowitz et al., 1998; McArron et al., 1998) . Despite this compelling clinical and preclinical data, the molecular basis by which apoE modifies the response of the brain to ischemia remains poorly defined. There are likely multiple mechanisms by which endogenous apoE plays a protective role in the injured CNS, as suggested by prior in vitro data demonstrating isoform-specific antioxidant (Miyata & Smith, 1996) and neurotrophic effects of apoE (Holtzman et al., 1995) .
An additional mechanism by which apoE might influence the CNS response to ischemia is via modulation of glutamate excitotoxicity. Glutamate toxicity is believed to contribute to neuronal injury in the setting of ischemia, and of the different classes of glutamate channels, specific activation of the N-methyl-d-aspartate (NMDA) receptor is believed to be primarily responsible for mediating excitotoxicity in a variety of neuron types (Meldrum & Garthwaite, 
